Table 7 Prognostic value of ALBI, MELD, MELD sarcopenia, and ALBI-Sarcopenia score to predict response to treatment.
From: ALBI-sarcopenia score as a predictor of treatment outcomes in hepatocellular carcinoma
AUC | P | 95% C. I | Cut off | Sensitivity | Specificity | PPV | NPV | ||
|---|---|---|---|---|---|---|---|---|---|
At 1 month (n = 190 vs. 72) | ALBI | 0.586 | 0.033* | 0.507–0.664 | ≤ – 2.01# | 62.11 | 56.94 | 79.2 | 36.3 |
MELD Sarcopenia | 0.609 | 0.006* | 0.533–0.685 | ≤ 18# | 67.37 | 52.78 | 79.0 | 38.0 | |
ALBI-Sarcopenia | 0.628 | 0.001* | 0.552–0.704 | ≤ – 10.18 | 62.63 | 58.33 | 79.9 | 37.2 | |
Sarcopenia | 0.0606 | 0.001* | 0.508–0.644 | 62.11 | 56.94 | 79.19 | 36.28 | ||
AFP | 0.701 | < 0.001* | 0.629–0.773 | ≤ 56.5 | 67.37 | 65.28 | 83.7 | 43.1 |